If you are interested in more information about a particular trial, please talk with your treating physician first, and they may contact this centre for further information if necessary.
|Tumour Group / Site||Trial Title||Opening Date|
|Breast||Prospective study to evaluate the feasibility of partial breast irradiation utilizing permanent breast seed implants in BC. (PBSI)||May|
|A feasibility Study of Accelerated Partial Breast Irradiation with High Dose Rate Interstitial , Multi-Catheter Brachytherapy for Women with Early Stage Breast Cancer. (HDR)||March 2013|
|Central Nervous System (CNS)||Feasibility study of randomization to 20 GY in 5 fractions whole brain radiotherapy versus 15 GY in one fraction for one to ten brain metastases. (BRAT STUDY)||March|
|Colorectal cancer tissue banking study.||January 2012|
|A phase II/III trial of Neoadjuvant Folfox, with selective use of combined modality chemoradiation versus preoperative combined modality chemoradiation for locally advanced rectal cancer patients cancer patients undergoing low anterior resection with total mesorectal excision. |
|GU - Bladder|
|GU- Prostate||Improving QOL after optimal RT for intermediate & high risk prostate ca: HDR vs. LDR Brachytherapy Boost. |
|GU - Renal|| A Phase III, multicenter, randomized Placebo-Controlled, Double-blind study of Atezolizumab (Anti-PD-L1 Antibody)|
as Adjuvant Therapy in Patients with Renal Cell Carcinoma at High Risk of Developing Metastasis Following Nephrectomy.
|GU - Multi|| |
|Gyne||A Randomized Placebo Controlled Phase ll trial Comparing Gemcitabine Monotherapy to Gemcitabine in Combination with AZD1775 (MK1775) PO in Women with Recurrent Platinum Resistant Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers. (PHL-093)||September|
|Lung||A Randomized Phase 3 Study of the Combination of Pembrolizumab (MK-3475) Plus Epacadostat (INCB024360) Alone or with Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo as First-Line Treatment in|
Patients with Metastatic Non-Small Cell Lung Cancer.
|A phase II study of Pembrolizumab in patients with advanced Malignant Pleural Mesothelioma (MPM). To evaluate whether pembrolizumab, alone or together with standard chemotherapy improves progression free survival in MPM.|
|Multiple Myeloma|| || |
|Multi-site||The OncoPanel Pilot Study. (TOP)|
|Supportive / Palliative Care|
|A randomized double-blind, double-dummy, 2-treatment, 2-period, cross-over comparison of sennosides and polyethylene glycol for constipation in outpatients with cancer. (Sennosides PEG)|